Published Aug 08, 2018

Harbour BioMed inks $350 million deal for rights to A167

Member News
Copy The Link to the  Article
Harbour BioMed inks $350 million deal for rights to A167
USA-based Harbour BioMed has entered into an exclusive strategic partnership with China’s Sichuan Kelun-Biotech Biopharmaceutical to develop and commercialize A167
Copy The Link to the  Article

Related or similar articles

View more News
March 13, 2019

Labshares Celebrates Grand Opening and Unveils Newly Expanded Shared Office and Lab Space in Newton

Labshares Newton's newly expanded facility features a cutting-edge lab and co-working space that can now accommodate up to 30 startups
Press Releases
June 13, 2024

Advancing Science at Labshares: Diagonal Therapeutics' Journey

Labshares News
November 2, 2018

Newton's First Life Sciences Incubator Set To Expand

Longtime biotech executive Jeff Behrens ventured out of the C-Suite earlier this year, opening the first life sciences-focused incubator in Newton. Now he's expanding the project amid broader demand for shared lab space.
Labshares News